tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Radiopharm Theranostics: Promising Pipeline and Strategic Advancements Drive Buy Rating
RatingsRadiopharm Theranostics: Promising Pipeline and Strategic Advancements Drive Buy Rating
15d ago
RADX
Radiopharm Theranostics Limited: Promising Clinical Developments and Strategic Growth Potential Drive Buy Rating
PremiumRatings
Radiopharm Theranostics Limited: Promising Clinical Developments and Strategic Growth Potential Drive Buy Rating
16d ago
RADX
Radiopharm reports FY25 closing cash balance $29.12M
PremiumThe Fly
Radiopharm reports FY25 closing cash balance $29.12M
16d ago
RADX
Radiopharm Theranostics Advances Clinical Programs with Key Milestones
PremiumCompany Announcements
Radiopharm Theranostics Advances Clinical Programs with Key Milestones
17d ago
RAD
Radiopharm receives IND approval from US FDA to initiate study of RV-01
PremiumThe Fly
Radiopharm receives IND approval from US FDA to initiate study of RV-01
17d ago
RADX
Radiopharm Theranostics Gains FDA Approval for Phase I Study of Innovative Cancer Treatment
PremiumCompany AnnouncementsRadiopharm Theranostics Gains FDA Approval for Phase I Study of Innovative Cancer Treatment
18d ago
RAD
Radiopharm appoints Sartor to Scientific Advisory Board
Premium
The Fly
Radiopharm appoints Sartor to Scientific Advisory Board
23d ago
RADX
Radiopharm Theranostics Appoints Dr. Oliver Sartor to Scientific Advisory Board
Premium
Company Announcements
Radiopharm Theranostics Appoints Dr. Oliver Sartor to Scientific Advisory Board
24d ago
RAD
Radiopharm initiated with a Buy at Brookline
PremiumThe Fly
Radiopharm initiated with a Buy at Brookline
24d ago
RADX
Radiopharm Theranostics Secures A$4.5 Million R&D Tax Incentive
PremiumCompany Announcements
Radiopharm Theranostics Secures A$4.5 Million R&D Tax Incentive
30d ago
RAD
Radiopharm, Cyclotek signs clinical supply agreement for Tb-KLK3-mAb
PremiumThe Fly
Radiopharm, Cyclotek signs clinical supply agreement for Tb-KLK3-mAb
2M ago
RADX
Radiopharm Theranostics Advances Prostate Cancer Trial with Cyclotek Partnership
PremiumCompany Announcements
Radiopharm Theranostics Advances Prostate Cancer Trial with Cyclotek Partnership
2M ago
RAD
Radiopharm Theranostics Limited – American Depositary Shares trading resumes
PremiumThe FlyRadiopharm Theranostics Limited – American Depositary Shares trading resumes
2M ago
RADX
Radiopharm Theranostics Announces Change in Substantial Holder Interests
Premium
Company Announcements
Radiopharm Theranostics Announces Change in Substantial Holder Interests
2M ago
RAD
Radiopharm Theranostics Issues New Shares, Ensures Compliance
Premium
Company Announcements
Radiopharm Theranostics Issues New Shares, Ensures Compliance
2M ago
RAD
Radiopharm Theranostics Expands Market Presence with New ASX Quotation
PremiumCompany Announcements
Radiopharm Theranostics Expands Market Presence with New ASX Quotation
2M ago
RAD
Radiopharm granted U.S. FDA FTD for RAD101
PremiumThe Fly
Radiopharm granted U.S. FDA FTD for RAD101
2M ago
RADX
Radiopharm Theranostics’ RAD 101 Receives FDA Fast Track Designation
PremiumCompany Announcements
Radiopharm Theranostics’ RAD 101 Receives FDA Fast Track Designation
2M ago
RAD
Radiopharm Theranostics Announces New Securities Issue
PremiumCompany Announcements
Radiopharm Theranostics Announces New Securities Issue
2M ago
RAD
Radiopharm announces dosing of first patient in Phase 1 HEAT trial
PremiumThe FlyRadiopharm announces dosing of first patient in Phase 1 HEAT trial
2M ago
RADX
Radiopharm Theranostics Initiates Phase 1 Trial for Novel Cancer Treatment
Premium
Company Announcements
Radiopharm Theranostics Initiates Phase 1 Trial for Novel Cancer Treatment
2M ago
RAD
Radiopharm reports preclinical Lu177-B7H3-mAb data
Premium
The Fly
Radiopharm reports preclinical Lu177-B7H3-mAb data
2M ago
RADX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >